Clinical Trials Logo
  1. Home
  2. Hypersensitivity, Immediate
  3. NCT02163122

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

Hypersensitivity, Immediate Clinical Trial

Official title:
A Pilot Study to Compare Responses to Cat Allergen Exposure Using the Environmental Exposure Chamber (EEC) and Nasal Allergen Challenge (NAC)

Clinical Trial Summary

This is a pilot trial in cat allergic participants, designed to compare allergic responses in each participant to a specific allergen by two methods of exposure. The methods of exposure to be used are: the environment exposure chamber (EEC) and nasal allergen challenge (NAC). Potential participants will be screened for evidence of cat allergy.

Participants with a range of allergic sensitivities to cat allergen will be enrolled. To help ensure some breadth in the level of allergic sensitivity among participants, individuals with both high and low exposures to cat allergens in their daily lives will be enrolled.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02163122
Study type Interventional
Source National Institute of Allergy and Infectious Diseases (NIAID)
Contact
Status Completed
Phase Early Phase 1
Start date January 2015
Completion date June 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT03563066 - Effect of Benralizumab in Atopic Dermatitis Phase 2
Completed NCT02916888 - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists N/A
Completed NCT01904604 - Peanut Epicutaneous Phase II Immunotherapy Clinical Trial Phase 2
Completed NCT03720470 - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Phase 3
Completed NCT03918772 - Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)
Completed NCT03688074 - Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) Phase 2
Completed NCT03054428 - Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis Phase 3
Recruiting NCT00312312 - Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide N/A
Completed NCT02162576 - Asthma Data Innovation Demonstration Project N/A
Active, not recruiting NCT00887939 - Pathogenesis of Physical Induced Urticarial Syndromes
Completed NCT03627767 - Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects Phase 3
Completed NCT04454229 - The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge N/A
Completed NCT00102570 - Clinical and Immunological Evaluation of Children With Allergies N/A
Completed NCT05661812 - Norwegian Birch Rust Allergy Study
Completed NCT02503800 - The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy
Recruiting NCT04322838 - Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?
Completed NCT01257191 - A Study to Compare the Effects of Different Sized Particles on Cells in the Nose Phase 1
Recruiting NCT05420935 - Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room N/A